Target intelligence / Profile preview

REXO4, RNA exonuclease 4 homolog (S. cerevisiae) (REXO4)

Target
REXO4
Molecular classification
Other, Nuclease, 3'-5' exonuclease
01

Overview

REXO4, also known as RNA exonuclease 4 homolog (S. cerevisiae), is a gene encoding a 3'-5' exonuclease involved in nucleic acid metabolism, particularly contributing to DNA repair and transcriptional regulation[4][6][7]. REXO4 is found in the nucleolus and nuclear specks and shows DNA binding and nuclease activity[4]. While REXO4 is a protein-coding gene, the entry "REX4, RNA exonuclease 4 homolog pseudogene" (ENSG00000259696, LOC400347) refers to a pseudogene and not to the functional REXO4 protein[4][6][7]. The functional REXO4 (not the pseudogene) has been implicated as an oncogenic factor in hepatocellular carcinoma where it is upregulated and is correlated with poor prognosis, increased proliferation, migration, and invasion of liver cancer cells[1]. It has also been linked to inflammatory and neurological conditions[1]. No drugs or specific mechanism-based therapies target REXO4 directly, nor are there established safety or druggability data for it. Note: The entry you provided (ENSG00000259696; LOC400347) describes a **pseudogene** homologous to REXO4, not an active target. Functional data relates to the protein-coding REXO4 gene (e.g., ENSG00000148300). Pseudogenes do not encode active proteins and are generally not considered therapeutic targets. This entry is **not a correct or actionable therapeutic target**.

Other names
Exonuclease XPMC2XPMC2HPrevents mitotic catastrophe 2 protein homologREX4, RNA exonuclease 4 homolog pseudogeneREX4, RNA exonuclease 4 homolog (S. cerevisiae) pseudogeneLOC400347PMC2
02

Biological functions

DNA repairDNA catabolic processRegulation of transcriptionRNA bindingNucleic acid metabolism
03

Disease associations

Cancer (implicated in hepatocellular carcinoma, familial solitary pituitary adenoma)Inflammation (neuropathic pain)Potential relevance in NAFLD-related liver cancer
04

Biomarkers

Prognostic biomarker for hepatocellular carcinoma[1]Potential marker for M2 polarization in neuropathic pain[1]

Beyond the preview

Go deeper on REXO4, RNA exonuclease 4 homolog (S. cerevisiae) (REXO4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on REXO4, RNA exonuclease 4 homolog (S. cerevisiae) (REXO4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call